Intercept Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 10.78, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Intercept Pharmaceuticals Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 34 days, from 33 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 129 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1262, from overall ranking in the second quarter 2023 at 1994.

What is Receivable Turnover Ratio?
What is Intercept Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ICPT Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	24.12 %	8.27 %	-37.71 %	-43.59 %	-43.32 %
Y / Y Revenue Change	14.44 %	16.67 %	-23.28 %	-16.43 %	-16.42 %
Receivable Turnover Ratio (TTM)	10.78	10.99	10.78	9.95	8.96
ICPT's Total Ranking	# 1262	# 1994	# 1213	# 1254	# 1823
Accounts Receivable average collection period days	34	33	34	37	41
Seq. Receivable Change	9.02 %	3.64 %	7.01 %	2.65 %	-4.9 %
Seq. Revenue Change	6.06 %	23.19 %	-11.99 %	-0.48 %	8.13 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 56
Healthcare Sector	# 130
Overall Market	# 1262

Receivable Turnover Ratio Statistics
High	Average	Low
10.99	8.7	7.21
(Jun 30 2023)		(Mar 31 2020)

ICPT Company Profile • Back to ICPT Efficiency Comparisons • Compare ICPT Receivables Turnover Ratio to its Competitors

Financial Statements
Intercept Pharmaceuticals Inc 's Accounts Receivable	$ 32 Millions	Visit ICPT's Balance sheet
Intercept Pharmaceuticals Inc 's Sales TTM	$ 318 Millions	Visit ICPT's Income Statement
Sources of ICPT's Revenues		Visit ICPT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ICPT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ICPT's Growth Rates	ICPT's Roa	ICPT's Inventory Turnover Ratio	ICPT's Dividend Comparisons
ICPT's Profitability Ratios	ICPT's Roi	ICPT's Asset Turnover Ratio	ICPT's Dividend Growth
ICPT's Valuation Ratios	ICPT's Roe	ICPT's Financial Strength Ratios	ICPT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
National Vision Holdings Inc	26.49	$ 2,088.996 Millions	$ 78.870 Millions
Capricor Therapeutics inc	25.66	$ 14.050 Millions	$ 0.548 Millions
Vireo Growth Inc.	25.38	$ 83.003 Millions	$ 3.270 Millions
Voyager Therapeutics Inc	25.34	$ 158.398 Millions	$ 6.250 Millions
Neuroone Medical Technologies Corp	25.25	$ 1.952 Millions	$ 0.077 Millions
Cue Health Inc	25.20	$ 198.915 Millions	$ 7.894 Millions
Molecular Templates Inc	23.22	$ 18.064 Millions	$ 0.778 Millions
Cv Sciences Inc	23.08	$ 15.578 Millions	$ 0.675 Millions
C4 Therapeutics Inc	23.06	$ 20.349 Millions	$ 0.882 Millions
Vaxart Inc	22.56	$ 4.156 Millions	$ 0.184 Millions
Mymetics Corporation	21.62	$ 1.229 Millions	$ 0.057 Millions
Ontrak Inc	21.60	$ 11.674 Millions	$ 0.541 Millions
Palvella Therapeutics Inc	21.38	$ 47.357 Millions	$ 2.215 Millions
Kiniksa Pharmaceuticals International Plc	20.83	$ 248.748 Millions	$ 11.944 Millions
Invo Fertility Inc	20.81	$ 1.917 Millions	$ 0.092 Millions
Marizyme Inc	19.60	$ 0.591 Millions	$ 0.030 Millions
Innovage Holding Corp	19.18	$ 699.354 Millions	$ 36.470 Millions
Adaptimmune Therapeutics Plc	18.82	$ 71.601 Millions	$ 3.805 Millions
Xoma Royalty Corporation	18.55	$ 4.411 Millions	$ 0.238 Millions
Plus Therapeutics Inc	18.55	$ 3.751 Millions	$ 0.202 Millions
Cano Health Inc	18.50	$ 3,101.906 Millions	$ 167.675 Millions
Valion Bio Inc	18.42	$ 1.331 Millions	$ 0.072 Millions
Qhslab Inc	17.62	$ 1.362 Millions	$ 0.077 Millions
Arvinas Inc	17.55	$ 167.200 Millions	$ 9.525 Millions
Recursion Pharmaceuticals Inc	17.18	$ 47.360 Millions	$ 2.756 Millions
Opus Genetics Inc	15.89	$ 57.208 Millions	$ 3.600 Millions
Lftd Partners Inc	15.79	$ 49.404 Millions	$ 3.129 Millions
Chemed Corporation	15.30	$ 2,225.159 Millions	$ 145.392 Millions
Patterson Companies Inc	14.56	$ 6,550.083 Millions	$ 449.864 Millions
Talkspace Inc	14.24	$ 137.071 Millions	$ 9.623 Millions

Date modified: 2026-08-29T17:25:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.